Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That ...

HealthDay News — In guidelines issued by the American Society of Hematology and published online Feb. 11 in Blood Advances, recommendations are presented for frontline management of acute ...

For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...

Eight recommendations and 1 research-only recommendation covering remission reinduction and consolidation were established. HealthDay News — In guidelines issued by the American Society of Hematology ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...

Potentially the Most Important Data Moment in Company HistoryEarly Blinded Results Show 40% Remission Rate Across ...

Severe CRS appeared numerically less frequent than in ZUMA-3, suggesting potential differences in patient selection, ...

Now, a step forward in genetic testing could help doctors look deeper than ever before to predict a patient's future health.

The Alliance for Clinical Trials in Oncology has launched a new clinical trial for adults who need first-line therapy for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The ...